undefined

Susan Krashinsky Robertson

Covers Canada's retail sector for The Globe and Mail. She reported on the Hudson's Bay Company's liquidation and the sale of its founding charter.

Top 3 podcasts with Susan Krashinsky Robertson

Ranked by the Snipd community
undefined
11 snips
Sep 9, 2025 • 24min

The multimillion-dollar fight over a piece of Canadian history

In this discussion, Susan Krashinsky Robertson, a retail journalist for The Globe and Mail, delves into the Hudson's Bay Company's founding charter from 1670. This unique document has sparked a multimillion-dollar debate over ownership and historical significance. Susan explores the challenges of selling such a pivotal artifact amid creditor pressures and highlights the bids from Canada's wealthiest families. Key issues arise around cultural implications, Indigenous rights, and who truly gets to own a piece of history.
undefined
10 snips
Aug 12, 2025 • 22min

Popeyes Chicken, covert surveillance and alleged rotting meat

Susan Krashinsky Robertson, a retail business reporter from The Globe, dives into the shocking allegations against Popeyes Chicken. She discusses a lawsuit claiming franchisees bought ‘unsafe’ meat from unauthorized sources. The conversation reveals corporate surveillance efforts to investigate quality control issues and questionable delivery practices. Robertson elaborates on the implications of such disputes for food safety and the brand's reputation, highlighting the complexities of maintaining standards in fast food franchising.
undefined
Dec 11, 2024 • 24min

The ‘miracle drug’ some dog owners regret using

Susan Krashinsky Robertson, a Globe business reporter, shares her insights on Librela, the controversial arthritis drug for dogs. Some pet owners celebrate its effects, claiming happier, more comfortable pets. However, troubling cases of adverse reactions, including severe lethargy and even death, raise serious concerns. Krashinsky discusses her interviews with pet owners and veterinarians, revealing a critical divide about the drug's safety and the need for better communication in veterinary care. The growing popularity of Librela prompts a closer examination of its risks and regulatory practices.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app